Journey Medical Corporation — Quarterly Cash Flow (NASDAQ:DERM) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 64.04 M80.24 M84.96 M81.16 M85.19 M Total liabilities 53.12 M60.17 M63.42 M61.91 M59.29 M Total equity 10.93 M20.07 M21.54 M19.25 M25.9 M Total liabilities & shareholders' equities 64.04 M80.24 M84.96 M81.16 M85.19 M Total debt ————— Net debt —————

Haberler

B.Riley, Journey Medical hissesi için Al notunu yineliyor, 12 dolar hedefini koruyor

B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target

Journey Medical Stock: Emrosi Is Winning, But The Stock Hasn't Noticed (NASDAQ:DERM)

FDA, Fortress Biotech’un Menkes hastalığı tedavisi için yeni PDUFA tarihi belirledi

16 haftalık kullanımdan sonra Minosiklin çalışması mikrobiyom bozulması göstermiyor

Minocycline study shows no microbiome disruption after 16-week use

Fortress Biotech, Menkes hastalığı tedavisi için NDA başvurusunu yeniden sundu

Journey Medical kazancı $0,06 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük

Journey Medical earnings missed by $0.06, revenue fell short of estimates

Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics

Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates

Cisco, Flutter, Manulife and more set to report earnings Wednesday